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Abstract 
A type I ribosome-inactivating protein, extracted and purified from M. charantia seeds, was crystallised by vapour diffusion with polyethylene 
glycol at pH 7.2. X-ray data were collected to 2.1 A resolution and the structure solved by molecular eplacement using the A-chain coordinates of 
ricin. The overall fold of the protein is similar to ricin but there are differences in secondary structure, on the surface and in the active site cleft. These 
differences are probably due in part to the evolution of the protein without a B-chain partner. The most extensive reorganisation occurs at the 
C-terminus whereas Tyr”’ shows the greatest change in the active site cleft. 
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1. Introduction 
A number of higher plants produce proteins capable 
of inactivating ribosomes. Type II RIPS, such as ricin 
from castor bean, comprise two protein subunits of sim- 
ilar size (approx. 2w, 30,000) linked by a disulphide 
bridge. The A-chain component is a highly specific N- 
glycosidase which excises a single base from a loop struc- 
ture within the 28 S RNA component of the eukaryotic 
ribosome [l,Z]. The B-chain component is a galactose- 
specific lectin which recognises cell surface glycoproteins 
and glycolipids and is mainly responsible for the endo- 
cytic internalisation of ricin and delivery of the A-chain 
component to the cytoplasm. Both the A- and B-chains 
of ricin are glycosylated and recognised by endocytic 
mannose receptors, providing a second route of cell entry 
[3]. Type II RIPS are thus extremely cytotoxic. Type I 
RIPS comprise only an A-chain component and exhibit 
much lower cytotoxicity. Indeed a number of these mate- 
rials are components of oriental herbal medicines. Much 
current interest exists in targeting the A-chain cell-killing 
function of RIPS to particular cell types by conjugation 
to antibodies and hormones [4]. Furthermore evidence 
exists that trichosanthin and momordin (the type I RIPS 
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Abbreviations: RIP, ~bosome-inactivating protein; RTA, ricin A-chain; 
RTC, recombinant ricin; MOM, momordin; PAP, pokeweed antivi- 
ral protein; FMP, formycin monophosphate; ApG, adenyl(3’-5’)gua- 
I PAGE, polyacrylamide gel electrophoresis. R,,, c = 
~~~,i-<~,zli~~~i~ri;R=~~(l jF,r,s/-/~dc/ i)/zh]Fobsg 
from Trichosanthes kirilowii Maximowicz and M. charan- 
tia) show selective toxicity to T-cells and macrophages 
infected by HIV [5,6]. 
There is therefore considerable interest in the structure 
and function of these proteins. Significant progress has 
been made by Robertus and co-workers in defining the 
3D structure of intact ricin [7l, recombinant ricin A- 
chain [8], pokeweed antiviral protein [9], and various 
substrate analogue complexes, and in proposing a mech- 
anism for the glycosidase activity [lO,ll]. In this paper 
we describe the 3D structure of momordin, a type I RIP 
derived from the seeds of the bitter gourd, M. charantia, 
which shows only 34% sequence similarity with ricin 
A-chain. The structural basis for the as yet incompletely 
defined variability in properties of type I RIPS may be 
an important factor in understanding their function and 
in engineering more selective cytotoxins. 
2. Experimental 
Momordin is an abundant constituent of iw. charantiu seeds and was 
purified using elements of previously published methods [13-l 51. Dried 
seeds (10 g), obtained from Dhaka, Bangladesh, were powdered and 
dispersed in phosphate-buffered saline (60 ml). Solids and oils were 
removed by filtration over Hyflo Supercel filter aid. Proteins were 
precipitated from the filtrate with ammonium sulphate (60% saturation 
at 4°C). Following centrifugation (48,000 x g for 30 min), the protein 
pellet was dissolved in 50 mM phosphate buffer pH 6.3 and gel-filtered 
over Sephadex G50 (2.6 x 97 cm) equilibrated in the same buffer. Frac- 
tions from a well resolved peak (M, 30,000, absorbance at 280 nm) were 
pooled, concentrated by ultrafiltration (M, 10,000 cut-off membrane) 
and the buffer changed to 20 mM sodium acetate, pH 4.5. Final purifi- 
cation was achieved by cation exchange chromatography on a 10 ml 
MonoS column at pH 4.5 where the major constituent eluted by a 
sodium chloride gradient (120 ml, o-0.5 M salt) was centred at 240 mM 
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salt (yield 100 mg). Progress of the purification was monitored by 
SDS-PAGE. 
The purified protein was desalted and concentrated to 20 mg/ml 
(absorbance at 280 nm = 1.3; 1 mg/ml; 1 cm path) by Centricon filtra- 
tion in 20 mM phosphate buffer, pH 7.4. C~s~IIisation conditions 
were screened by hanging-drop vapour diffusion methods. X-ray data 
were collected using a MARResearch image plate mounted on a 
Siemens XP-18 rotating anode generator operating at 40 kV and 100 
mA. Molecular replacement procedures were performed using the coor- 
dinates of the ricin A-chain as the search model. Normalised structure- 
factor amplitudes were employed in a fast cross-rotation function [16]. 
The positioned ricin model in the momordin unit cell was subjected to 
rigid body refinement. The atomic model was refined with geometrical 
restraints against he observed amplitudes using RESTRAIN [17]. Only 
common side chains were included initially, with others set as alanine. 
The main chain density in early difference maps was fragmented into 
17 sections. Multiple rounds of refinement using both XPLOR [ 181 and 
PROLSQ [ 191 were interspersed with computer-graphics rebuilds using 
FRODO [20], gradually building in the side chains of the momordin 
sequence [21]. Once a satisfactory description of the protein density was 
complete, water molecules were added. The refined model was com- 
pared with ricin A-chain, recombinant ricin A-chain, pokeweed antivi- 
ral protein and their complexes with formycin monophosphate and 
dinucleotides [lo]. 
3. Results and discussion 
Well-formed rhombohedral crystals grew over 2 weeks 
equilibration against 2040% w/v polyethylene glycol 
4000 at pH 7.4 +_ 0.2. Crystal constants and X-ray data 
collection statistics are recorded in Table 1. This form is 
similar to that reported previously [22]. Inclusion of lac- 
tose as a crystallisation additive (10 mM) produced iso- 
morphous crystals with an altered morpholo~ and im- 
proved diffraction characteristics although no evidence 
of bound disaccharide was eventually found. The refined 
electron density clearly matched the amino acid sequence 
of momordin 1 [21], except at residue 64 where it is a 
leucine instead of a valine. 
The cross-rotation function using the coordinates of 
ricin A-chain, data from 8 to 3 A resolution and a radius 
of integration of 25 A provided a solution 6.5 (r above 
the mean and 1.6 cr above the highest random-noise 
peak. Fourier coefficients of the Z’,-function [23] were 
computed and the translation function map showed a 
clear solution 4.1 o above the highest random-noise 
peak. The rotation and translation parameters provided 
an acceptable packing arrangement in the momordin 
cell. Rigid body re~nement resulted in R = 0.496, and 
correlation coefficient = 0.285 for data between 10.0 and 
Table 1 
X-ray diffraction data for momordin 
Space group 
Cell constants 
Number of molecules in ascetic unit 
Average redundancy 
Number of unique reflections used 
Maximum resolution 
R 
CZpleteness 
R3 
a = 131.17 A, c = 40.75 A 
1 
4.5 
13591 
2.16 A 
0.100 
96.9% 
Phi (degrees) 
Fig. 1. A Ramachandran plot showing main chain (#,q) conformational 
angles of momordin. The glycine residues are shown as triangles. All 
residues but one (Asp”) are within the allowed regions of the Rama- 
chandran plot. 
2.8 8, resolution. The final momordin model, which in- 
cluded 197 water molecules, gave R = 0.187 for all data 
between 8.0 and 2.16 A resolution. Table 2 lists least- 
squares refinement statistics and Fig. 1 is a Ramachan- 
dran plot [24] (‘produced by PROCHECK [25]) showing 
(4,~) values of momordin. Fig. 2 shows Asp7’ in a very 
tight type II /I-turn normally occupied by glycine (as is 
the equivalent residue in ricin), with (@A) = (65”,-100”) 
in a normally disallowed region. Similar occurrences 
have been observed elsewhere [26,27]. 
Ribbon diagrams [28] of the secondary structures of 
momordin and ricin are shown in Fig. 3a and b. Ricin 
A-chain has a greater accessible surface area than 
momordin (by 1,369 A’); the ribbon diagram illustrates 
that this is a consequence of sequence insertions in sur- 
face loops and the presence of extensive secondary struc- 
Table 2 
Least squares refinement statistics of momordin 
Number of protein atoms 
Number of solvent atoms 
Number of carbohydrate atoms 
Resolution range 
Number of reflections used in refinement 
rms deviation from target values: 
Bond lengths 
Bond angles 
Peptide planarity 
Mean B-values: 
All protein atoms 
Main chain atoms 
Side chain atoms 
Solvent atoms 
R-factor 
1958 
194 
28 
8.0-2.16 A 
13591 
0.016 A 
0.047 A 
0.060 A 
28.6 A” 
26.7 AZ 
30.5 A2 
53.4 A” 
0.187 
156 J. Husain et ai.IFlXS Letters 342 {19941 54--15X 
Fig. 2. A stereo view of A$’ and the (2 / Fobs / - / Fcalc /) electron density contoured at 1 cr. 
ture elements near the surface. The published sequence 
[21] for momordin contains 263 amino acids, but there 
is electron density for only 246 of them. The missing 
residues are located at the C-terminus. This may either 
be due to disorder or to proteolytic processing. A similar 
truncation has been reported for trichosanthin 1291. Of 
the 15 available sequences for RIPS from plant and bac- 
terial origins, momordin shows the closest similarity 
(60%) with trichosanthin. Unlike trichosanthin, how- 
ever, momordin is glycosylated at Asn2” [30]. Electron 
density is visible for the first N-acetyl glucosamine on 
strand h but there is weaker density for the second ring 
which, being adjacent o an extensive solvent channel on 
the crystal 3, axis, is probably disordered. 
Robertus and co-workers have described the ricin fold 
in three regions [7]. A 6-stranded (a--Q twisted sheet with 
four central antiparallel strands and parallel outer 
strands is flanked by two helices, A and B. In momordin 
there are two additional antiparallel strands which, in 
keeping with the prime nomenclature of ricin we refer to 
as a’ and a”. The central region of the molecule is made 
up of the eight helices, A-H, which enclose the active site 
cleft. Helices A, B, D, and G are shorter in momordin, 
whereas in the C-terminal region additional irregular 
helical regions occur. Residues 216-221 of the loop con- 
necting strands g and h and residues 242-246 have hy- 
drogen bond patterns and dihedral angles approaching 
that of a-helix. The most regular region 230-235 is 
shown in the ribbon diagram in Fig, 3a. 
A number of residues in the active site cleft are identi- 
cal across the RIP family and mutagenesis experiments 
[10,31] have confirmed their importance to the enzyme 
mechanism [ 111. Structural studies of ricin and PAP com- 
plexed with formycin S-monophosphate, and ricin with 
the dinucleotide ApG show the adenine base sandwiched 
between Tyr*’ and Tyriz3 (ricin numbering). A mecha- 
nism has been proposed which focuses on G~u’~~ and 
Arg”’ as central catalytic residues. The organisation of 
these residues is very similar in momordin with the ex- 
ception of Tyr7’ (Tyr’” in ricin). This side chain occupies 
Fig. 3. A ribbon diagram showing the very similar secondary structures 
of {a) momordin and (b) r~ombinant ricin A-chain despite their low 
sequence similarity (34%). The carbohydrate attachment point in 
momordin is indicated as CHO. Side chains of active site residues 
Tyr70 = Y, GIu’~ = E, Arg’63 = R and Trp19* = W in momordin (and 
their equivalents in ricin) are atso labelled. 
a range of positions [8-10,121 in intact ricin, recombinant 
ricin A-chain, PAP and their complexes. Although the 
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tms fit of 215 Ca of the above mentioned RIPS (shown 
in Fig. 4) is only 0.9 A, the rms fit of Tyr7’ and its 
equivalents alone is 0.6 A. This suggests that some of 
these differences may be related to an activation event on 
release of the ricin B-chain. The ring position in momor- 
din most closely resembles that in PAP, which is also a 
type I RIP. The tyrosine ring effectively screens the ac- 
tive site Trp 192 from solvent in momordin whereas it is 
exposed in other unliganded structures. The electron 
density for Trp 192 also indicates that this side chain may 
adopt two different confo~ations. The ring plane is 
retained in both conformations but the ring is flipped 
over to provide H-bonding from NE2 either to Leu239C0 
or Tyr’” via a water molecule. When we model FMP into 
the momordin cleft it is necessary to disturb the syn 
conformation observed in ricin complexes to accommo- 
date Tyr”. The significance of this observation is not 
clear as it has been previously noted that FMP is not an 
effective inhibitor of ricin, althou~ it is an excellent 
transition state mimic inhibitor for AMP nucleosidase, 
an enzyme that catalyses an analogous reaction. Further- 
more, crystals of riein, recombinant ricin A-chain, PAP 
and momordin grow at pH values between 4.8 and 8.9. 
Both PAP and momordin crystallise at about the same 
pH and have the most similar organisation for Tyr”, 
suggesting that pH might be a significant and not unex- 
pected determinant of the detailed active site geometry. 
Although the central active site residues are identical 
across the family, adjacent residues involved in defining 
their positions do vary to some degree. G~u’~ and Arg’63 
in momordin (equivalents of 177 and 180 in ricin) pro- 
trude into the cleft from a distorted C-terminal segment 
of helix E. This segment is defined by a break in the 
continuous hydrogen bonding pattern of the long central 
helix E; a stereo view of helix E is shown in Fig. 5. The 
pattern break is clearest at Thr’57 the carbonyl of which 
forms a hydrogen bond with the conserved Tyr14 side 
chain from nearby helix A. This arrangement and the 
degree of deviation of the dihedral angles is very close to 
that observed in ricin. The first residue beyond this kink 
Fig. 4. Su~~mpositions of the 3D structures of MOM, PAP, RTC, 
FMP, APG and RICIN are shown. 215 Cas of the RIPS were least- 
squares fitted by MNYFIT [32]; the rms fit is 0.9 A. Tyr?’ in the active 
site of momordin is compared with those of PAP (numbered 587), ricin 
complexes APG (1,124) and FMP (1,391), recombi~nt ricin A-chain 
(328) and ricin A-chain (857). Momordin is most similar to PAP 
in helix E in ricin, Ser176, does not cap the continuing 
helix but forms a buried hydrogen bond with Ala79C0 
of the c/d loop which visits the cleft. The equivalent 
residue Ala 159 in momordin cannot make this stabili- 
sing hydrogen bond and this region of the helix may as 
a result enjoy more flexibility. Furthermore, the substitu- 
tion of buried hydrophobic residues Met’74 and Ile’75 in 
ricin by buried hydrogen-bonded threonines in momor- 
din may also lead to stability differences in the C termi- 
nus of helix E. Thr”’ and Thr”’ side chains and NHs 
share hydrogen bonds with Va1’53C0 and Leu’YO. It 
remains to be established what variability in catalytic 
Fig. 5. A stereo view of the C-terminal region of helix E showing the distinctive hydrogen-bonding pattern of momordin adjacent o the active site 
residues Arg16” and Glu’@‘. 
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constants, if any, is shown by different RIPS, which may 
be related to these differences in active site organisation. 
The interchain disulphide bond in the ricin heterod- 
imer is formed through the A-chain Cyszs9. This is lo- 
cated in the extended chain of the C-terminal region (Fig. 
3b). Preceding this cysteine is a stretch of 10 hydrophobic 
amino acid residues, some of which are buried in the 
isolated A-chain and others which become buried on 
interaction with the B-chain. It has been suggested that 
this region might be involved in the translocation of the 
A-chain through membranes. In momordin, residues at 
these positions co~esponding to exposed hydrophobics 
in the ricin A-chain are either buried by modifications to 
the fold or substituted by hydrophilic side chains. Equiv- 
alent modifications are also observed in PAP. Both pro- 
teins have evolved to a more stable solvent interaction 
surface and have lost the cysteine residue. 
There are some indications that in spite of the strong 
conservation of the catalytic residues among members of 
the RIP family, there exists a degree of specificity in the 
action of RIPS on ribosomes from different species. Ricin 
A-chain, for instance, does not attack E. coli ribosomes 
whereas PAP does. This is not unexpected in that ribo- 
some binding probably involves regions of the RIPS re- 
mote from the active site. Details of the 3D structure in 
surface regions are likely to become of increasing interest 
to those engineering toxins of defined target specificity, 
particularly with respect o recognition of virally infected 
cells. 
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